Regulatory requirements in the UK in the 1990s

Abstract

The UK Medicines Act was enacted in 1968 and its major provisions first came into force in 1971. Broadly speaking the Act controls almost all aspects of manufacture, development and marketing of drugs. The principal variants that it does not control are price, need and supply for administration to healthy volunteers. Price and need are taken into account elsewhere in the Department of Health and Social Security (DHSS) for determining reimbursement of certain groups of products.